-
公开(公告)号:DE69707497D1
公开(公告)日:2001-11-22
申请号:DE69707497
申请日:1997-12-04
Applicant: ABBOTT LAB
Inventor: MEYER D , ALTENBACH J , BASHA FATIMA , CARROLL A , DRIZIN IRENE , KERWIN F , WENDT D , HAIGHT R , ZHANG WEIJIANG
IPC: A61K31/517 , A61K31/519 , A61P13/08 , A61P13/10 , A61P15/04 , A61P43/00 , C07D207/26 , C07D311/58 , C07D491/04 , C07D491/052 , C07D495/04 , C07D519/00 , A61K31/415
Abstract: The present invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 adrenoreceptors and treating BPH.
-
公开(公告)号:ES2159721T3
公开(公告)日:2001-10-16
申请号:ES96903364
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR
IPC: A61K31/505 , A61K31/519 , A61P13/02 , A61P15/00 , A61P25/02 , C07D401/06 , C07D403/06 , C07D471/04 , C07D473/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D491/056 , C07D495/04 , C07D498/04 , C07D487/02 , C07D495/02 , C07D487/00
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:DK0805812T3
公开(公告)日:2001-09-17
申请号:DK96903364
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: BASHA FATIMA Z , TIETJE KARIN R , MEYER MICHAEL D , ALTENBACH ROBERT J , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , PRATT JOHN K , YAMAMOTO DIANE M , SIPPY KEVIN B
IPC: A61K31/505 , A61K31/519 , A61P13/02 , A61P15/00 , A61P25/02 , C07D401/06 , C07D403/06 , C07D471/04 , C07D473/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D491/056 , C07D495/04 , C07D498/04 , C07D487/02 , C07D487/00 , C07D495/02
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:HU0100112A2
公开(公告)日:2001-08-28
申请号:HU0100112
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , DRIZIN IRENE , HOLLADAY MARK W , SULLIVAN JAMES P , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:CO5040063A1
公开(公告)日:2001-05-29
申请号:CO98074895
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/34 , A61K31/38 , A61K31/44 , A61K31/47 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14
Abstract: Un compuesto de fórmula Ió una sal, éster, amida, ó precursor de droga farmacéuticamente aceptables de éste.en dondeR1 es alquil;R2 se selecciona del grupo conformado por aril y heteroaril: en donde el aril está opcionalmente sustituido con 1-5 sustituyentes independientemente seleccionados entre alcanoil, alquenil, alcoxi, alcoxialcoxi, alquil, alquilsulfinil, alquilsulfonil, alcoxicarbonil, alquinil, aril, azido, carboxi, ciano, halo, haloalquil, haloalcoxi, heteroaril, hidroxi, nitro tioalcoxi, -C(O)NR6 R7 (en donde R6 y R7 son independientemente hidrógeno, alquil ó aril), tioureido, ureido y -S(O)p NR6 R7 ó el heteroaril esta opcionalmente sustituido con 1-4 sustituyentes independientemente seleccionados entre alcanoil, alquenil, alcoxi, alquil, alquilsulfinil,alquilsulfonil, alcoxicarbonil, alquinil, aril, azido, carboxi, ciano, halo, haloalquil, haloalcoxi, heteroaril, hidroxi, hidroxialquil, nitro, tioalcoxi, -C(O)NR6 R7 (en donde R6 y R7 son independientemente hidrógeno, alquil o aril), tioureido, ureido, y -S(O)p NR6 R7 .;n es O-2;A se selecciona del grupo conformado por hidrógeno, alquil, y -X-R3 ;en donde R3 es alquil o haloalquil; X es -CO(O)- ó -S(O)p - en donde p es 1-2;R4 y R5 se seleccionan independientemente del grupo conformado por hidrógeno, alquil y haloalquil; óR1 y R5 junto con el anillo al cual van ligados forman un anillo que contiene azufre de 5, 6 ó 7 miembros con 1 ó 2 dobles enlaces y con O - 2sustituyentes oxo; óA y R4 junto con el anillo al cual van ligados forman un anillo seleccionado del grupo conformado por un anillo carbocíclico de 5, 6 ó 7 miembros con1 ó 2 dobles enlaces y 0 ó 1 sustituyente oxo y un anillo que contiene azufre de 5, 6 ó 7 miembros con 1 ó 2 dobles enlaces y con O - 2 sustituyentesoxo, a condición de que por lo menos uno de los sustituyentes R1 y R5 ó A y R4 forman un anillo.
-
公开(公告)号:PL341298A1
公开(公告)日:2001-04-09
申请号:PL34129898
申请日:1998-12-16
Applicant: ABBOTT LAB
Inventor: CARROLL WILLIAM A , HOLLADAY MARK W , SULLIVAN JAMES P , DRIZIN IRENE , ZHANG HENRY Q
IPC: A61K31/4365 , A61K31/47 , A61K31/4743 , A61P1/00 , A61P1/14 , A61P9/08 , A61P9/12 , A61P11/06 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , C07C45/29 , C07D215/36 , C07D221/04 , C07D495/04 , C07D495/14 , C07D211/84 , A61K31/44 , A61K31/38
Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
-
公开(公告)号:DE69609051T2
公开(公告)日:2001-03-22
申请号:DE69609051
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER D , ALTENBACH J , BASHA Z , CARROLL A , DRIZIN IRENE , KERWIN F , LEBOLD A , LEE L , ELMORE W , SIPPY B , TIETJE R , WENDT D , YAMAMOTO M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:ES2149451T3
公开(公告)日:2000-11-01
申请号:ES96903340
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16 , A61K31/395
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:AT194141T
公开(公告)日:2000-07-15
申请号:AT96903340
申请日:1996-01-11
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA Z , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F JR , LEBOLD SUZANNE A , LEE EDMUND L , ELMORE STEVEN W , SIPPY KEVIN B , TIETJE KARIN R , WENDT MICHAEL D , YAMAMOTO DIANE M
IPC: A61K31/437 , A61K31/519 , A61P13/00 , A61P13/08 , A61P43/00 , C07D403/06 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/04 , C07D491/048 , C07D491/14 , C07D491/147 , C07D495/04 , C07D495/14 , C07D487/16
Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an alpha -1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are alpha -1 antagonist compositions and a method for antagonizing alpha -1 receptors and treating BPH.
-
公开(公告)号:BR9713682A
公开(公告)日:2000-03-28
申请号:BR9713682
申请日:1997-12-04
Applicant: ABBOTT LAB
Inventor: MEYER MICHAEL D , ALTENBACH ROBERT J , BASHA FATIMA , CARROLL WILLIAM A , DRIZIN IRENE , KERWIN JAMES F , WENDT MICHAEL D , HAIGHT ANTHONY R , ZHANG WEIJIANG
IPC: A61K31/415 , C07D491/04
-
-
-
-
-
-
-
-
-